• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 0.25%

    Myriad Genetics Inc. (MYGN)

    -NasdaqGS
    32.96 Down 0.99(2.92%) Jun 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:33.95
    Open:33.77
    Bid:32.25 x 200
    Ask:37.90 x 500
    1y Target Est:36.23
    Beta:0.13
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:32.75 - 33.98
    52wk Range:31.56 - 40.50
    Volume:758,782
    Avg Vol (3m):682,723
    Market Cap:2.29B
    P/E (ttm):26.30
    EPS (ttm):1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MYGNDown 2.92%2.29B
    ABTUp 0.70%72.86B

    Key Statistics

    Forward P/E (1 yr):18.62
    P/S (ttm):3.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :1.45
    Quarterly EPS Est (Jun-15) :0.41
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):1.67

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback